North America Peptide Synthesis Market Size & Outlook
The peptide synthesis market in North America is expected to reach a projected revenue of US$ 696.4 million by 2033. A compound annual growth rate of 7.3% is expected of North America peptide synthesis market from 2025 to 2033.
In terms of revenue, North America region accounted for 39.0% of the global peptide synthesis market in 2024.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 442.5 million by 2033.
North America peptide synthesis dominated the global market with the largest revenue share of 38.95% in 2024. The dominance can be attributed to its highly developed pharmaceutical sector, well-developed technology, favorable regulations, and a greater focus on the biopharmaceutical industry.
For instance, in May 2024, Donaldson Company and PolyPeptide Group AG announced a collaboration to develop a production-scale solvent recovery system to enhance sustainability in peptide manufacturing. This system, piloted at PolyPeptide’s Torrance, California facility, utilizes a patented three-step technology to reclaim and purify acetonitrile, a solvent commonly used in peptide purification.
By removing water content from solvent mixtures, the system recycles acetonitrile to a purity level suitable for reuse, significantly reducing solvent consumption and waste generation while maintaining high product purity, further fueling the demand in the region.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Peptide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Reagents & Consumables was the largest segment with a revenue share of 51.75% in 2024.
Horizon Databook has segmented the North America peptide synthesis market based on reagents & consumables, equipment, service covering the revenue growth of each sub-segment from 2021 to 2033.
North America peptide synthesis dominated the global market with the largest revenue share of 38.95% in 2024. The dominance can be attributed to its highly developed pharmaceutical sector, well-developed technology, favorable regulations, and a greater focus on the biopharmaceutical industry.
For instance, in May 2024, Donaldson Company and PolyPeptide Group AG announced a collaboration to develop a production-scale solvent recovery system to enhance sustainability in peptide manufacturing. This system, piloted at PolyPeptide’s Torrance, California facility, utilizes a patented three-step technology to reclaim and purify acetonitrile, a solvent commonly used in peptide purification.
By removing water content from solvent mixtures, the system recycles acetonitrile to a purity level suitable for reuse, significantly reducing solvent consumption and waste generation while maintaining high product purity, further fueling the demand in the region.
North America Peptide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
Reagents & Consumables
Equipment
Service
North America Peptide Synthesis Market Technology Outlook (Revenue, USD Million , 2021-2033)
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Hybrid Technology
North America Peptide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
Therapeutics
Research
Diagnosis
North America Peptide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical & Biotechnology Companies
CDMOs & CROs
Academic & Research Institutes
Reasons to subscribe to Peptide Synthesis Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Peptide Synthesis Market Outlook databook
Our clientele includes a mix of Peptide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Peptide Synthesis Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Peptide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Peptide Synthesis Market, 2021-2033 (US$M)